Blood test may reveal how lung cancer patients react to immunotherapy

NCT ID NCT06823401

Recruiting now Knowledge-focused Sponsor: Fondazione Ricerca Traslazionale Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is for people with non-small cell lung cancer who are about to start immunotherapy. Researchers want to see if the body makes antibodies against the immunotherapy drugs. By collecting blood samples from 270 participants, they hope to learn more about how the immune system responds to treatment. This is an observational study, meaning it does not test a new treatment but gathers information to improve future care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NSCLC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NSCLC

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Istituto Tumori Regina Elena
ENROLLING_BY_INVITATION

Roma, RM, 000144, Italy
Istituto Tumori Regina Elena
RECRUITING

Roma, RM, 00128, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.